Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    15564544 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Providing Access to Cord Blood Units for Transplants
Conditions: Chronic Myelogous Leukemia/Other Leukemia;   Acute Leukemias;   MDS/MPS;   Multiple Myeloma;   Non-Hodgkin Lymphoma
Intervention: Drug: Access to unlicensed cord blood units
2 Terminated Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Conditions: Leukemia;   Non-Hodgkins Lymphoma;   Hodgkins Lymphoma;   MDS;   Multiple Myeloma
Interventions: Drug: EPOCH-F/R;   Drug: FLAG;   Drug: Transplant Preparative Regimen (Flu/Cy/Mes);   Drug: GVHD Prophylaxis (tacrolimus and sirolimus);   Procedure: Double Cord Blood Transplantation
3 Recruiting Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Condition: Leukemia
Intervention: Other: DLI of the 20 fraction of the UCBT
4 Not yet recruiting Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies
Condition: Leukemia, Myeloid
Interventions: Drug: IV Thiotepa;   Drug: IV Fludarabine;   Drug: IV Busulfan;   Drug: IV Anti-thymocyte globuline

Indicates status has not been verified in more than two years